Mentioned in this article
Coeptis Therapeutics Holdings Inc (COEP) is near the middle in its industry group according to InvestorsObserver. COEP gets an overall rating of 42. That means it scores higher than 42 percent of stocks. Coeptis Therapeutics Holdings Inc gets a 42 rank in the Biotechnology industry. Biotechnology is number 45 out of 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 42 would rank higher than 42 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What’s Happening With Coeptis Therapeutics Holdings Inc Stock Today?
Coeptis Therapeutics Holdings Inc (COEP) stock is down -5.37% while the S&P 500 is up 0.11% as of 11:41 AM on Tuesday, Feb 7. COEP is down -$0.07 from the previous closing price of $1.40 on volume of 287,931 shares. Over the past year the S&P 500 is down -8.21% while COEP is down -86.85%. COEP earned $0.12 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 11.21.
Click Here to get the full Stock Report for Coeptis Therapeutics Holdings Inc stock.